Montreal, QC (October 29, 2025) — The Quebec Society of Vascular Sciences (QSVS) is launching a new artificial intelligence chat tool, Amelia, on the Vascular Health portal, www.yourvascularhealth.ca. This initiative, developed in partnership with Boehringer Ingelheim Canada, is designed to empower Canadians by making information developed by vascular health experts more accessible to the public and to support healthcare professionals in their educational efforts.
Amelia provides real-time tailored responses and reduces the clutter of information overload. Users can interact with the portal in a natural, conversational format, making complex health topics more accessible for people living with vascular conditions such as deep vein thrombosis, diabetic foot, high blood pressure, peripheral artery disease, pulmonary embolism, Raynaud’s phenomenon, etc., as well as their families and caregivers.
“This initiative reflects our commitment to improving access to reliable information about vascular health,” said Dr. Michel Vallée, nephrologist and president of the QSVS. “By incorporating conversational AI, we’re making it easier for individuals, caregivers and healthcare professionals to engage with the information they need when they need it.”
“Amelia feels like you have someone next to you who really understands your questions, even when they are not worded as they would be in a medical textbook, and she answers in a simple and clear way. It is reassuring and, above all, accessible to everyone,” said Nathalie Gélinas, patient-partner on the board of QSVS. “When faced with a diagnosis, anxiety and confusion often take over and it’s hard to know what to ask. What I appreciate most about Amelia and www.yourvascularhealth.ca portal is how they provide reliable information, based on medical experience, in language that makes sense. When it comes to our health, access to trusted expert guidance isn’t just helpful—it’s essential.”
Designed to improve public understanding and minimize health risks, the AI tool serves as a powerful resource to raise awareness of vascular disease and symptoms. Promotes the importance of maintaining healthy veins and arteries as a cornerstone of prevention and early detection.
With more than 7,700 healthcare professionals in its network, QSVS remains at the forefront of advancing innovation and knowledge sharing in vascular care.
Key features:
- Simple and bilingual: Just type your questions. Available in both English and French.
- Easy sharing: You can forward conversations via email or print them to keep for future reference.
- The mobile app will soon be available for iOS and Android so you can access it on the go.
“At Boehringer Ingelheim Canada, we are proud to support innovative initiatives that empower patients and increase access to reliable health information,” says Dr. Rasha Eldesouky Abouelabbas, Vice President of Medical and Regulatory Affairs, Boehringer Ingelheim Canada. “This partnership with QSVS reflects our shared commitment to improving the lives of Canadians affected by vascular disease.”
The Vascular Health Portal focuses on prevention and education, addressing risk factors such as obesity, smoking, physical inactivity, poor diet, hypertension and diabetes. The AI tool will build on this foundation, offering a more accessible and interactive way to explore the portal’s content.
***
About the Quebec Society of Vascular Sciences (QSVS)
QSVS is a charitable organization dedicated to promoting professional exchange between a variety of health professionals (family doctors, specialists, nurses, pharmacists, nutritionists and others) and informing the public about vascular health. Through initiatives such as www.yourvascularhealth.ca portal and Amelia, QSVS promotes research, innovation and excellence in patient care across Quebec and Canada.
***
Boehringer Ingelheim (Canada) Ltd.
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s leading investors in research and development, the company focuses on developing innovative therapies that can improve and extend life in areas of high unmet medical need. Independent since its founding in 1885, Boehringer has taken a long-term perspective, integrating sustainability throughout the entire value chain. More than 53,500 employees serve more than 130 markets to build a healthier, more sustainable and fairer tomorrow. Boehringer Ingelheim’s Canadian headquarters was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 500 people across Canada.
—
Sign up for The Good Men Project newsletter
(function($) { window.fnames = []; window.ftypes = []; fnames[0]=’EMAIL’; ftypes[0]=’email’; })(jQuery); var $mcj = jQuery.noConflict(true);
If you believe in the work we do here at The Good Men Project, join us as a Premium Member today.
All Premium members can watch The Good Men Project ADS-free.
Need more information? A full list of benefits is here.
Photo source: iStock
The post New AI chat tool helps Canadians navigate vascular health appeared first on The Good Men Project.
